Perimeter Medical Imaging AI (TSE:PINK) has released an update.
Perimeter Medical Imaging AI has reported a significant increase in commercial market traction with a 83% growth in Q2-2024 revenues and doubled its year-to-date placements of its FDA-cleared Perimeter S-Series OCT systems. Additionally, the company has made strides in its clinical trial for the next-generation Perimeter B-Series OCT, expecting to complete patient enrollment earlier than anticipated, and has introduced an AI enhancement to its existing systems showing marked improvements in image quality and scan time.
For further insights into TSE:PINK stock, check out TipRanks’ Stock Analysis page.
